David Toung
Stock Analyst at Argus Research
(4.35)
# 242
Out of 4,829 analysts
120
Total ratings
64.52%
Success rate
10.55%
Average return
Main Sectors:
Stocks Rated by David Toung
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMO Thermo Fisher Scientific | Maintains: Buy | $620 → $470 | $403.13 | +16.59% | 7 | Apr 29, 2025 | |
| UNH UnitedHealth Group | Downgrades: Hold | n/a | $380.64 | - | 8 | Apr 21, 2025 | |
| IART Integra LifeSciences Holdings | Upgrades: Buy | n/a | $12.25 | - | 2 | Mar 31, 2025 | |
| ELV Elevance Health | Reiterates: Hold | $405 | $404.58 | +0.20% | 1 | Jan 29, 2025 | |
| ABBV AbbVie | Upgrades: Buy | n/a | $184.60 | - | 6 | Nov 4, 2024 | |
| CAH Cardinal Health | Maintains: Buy | $115 → $125 | $148.22 | -15.67% | 9 | Sep 11, 2024 | |
| CRL Charles River Laboratories International | Downgrades: Hold | n/a | $138.79 | - | 5 | Jun 28, 2024 | |
| AMGN Amgen | Maintains: Buy | $300 → $340 | $265.86 | +27.89% | 10 | Jun 27, 2024 | |
| MCK McKesson | Maintains: Buy | $570 → $670 | $693.46 | -3.38% | 6 | Jun 24, 2024 | |
| ZBH Zimmer Biomet Holdings | Upgrades: Buy | $150 | $95.21 | +57.55% | 7 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $770 → $840 | $734.57 | +14.35% | 3 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $89 → $95 | $56.75 | +67.40% | 1 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $69.87 | +57.44% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $245.73 | - | 1 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $22.28 | - | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $249.53 | - | 8 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $380.92 | -18.62% | 2 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $353.70 | -12.36% | 2 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $265 → $320 | $536.51 | -40.36% | 3 | Dec 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $135 | $133.24 | +1.32% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $75 | $96.91 | -22.61% | 5 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $46.45 | - | 4 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $110 | $75.97 | +44.79% | 3 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $165 | $83.48 | +97.65% | 6 | Aug 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $7.11 | - | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $123 | $49.94 | +145.29% | 3 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $67.57 | - | 4 | Apr 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $108.70 | - | 3 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $165 → $155 | $154.22 | +0.51% | 4 | Mar 27, 2020 |
Thermo Fisher Scientific
Apr 29, 2025
Maintains: Buy
Price Target: $620 → $470
Current: $403.13
Upside: +16.59%
UnitedHealth Group
Apr 21, 2025
Downgrades: Hold
Price Target: n/a
Current: $380.64
Upside: -
Integra LifeSciences Holdings
Mar 31, 2025
Upgrades: Buy
Price Target: n/a
Current: $12.25
Upside: -
Elevance Health
Jan 29, 2025
Reiterates: Hold
Price Target: $405
Current: $404.58
Upside: +0.20%
AbbVie
Nov 4, 2024
Upgrades: Buy
Price Target: n/a
Current: $184.60
Upside: -
Cardinal Health
Sep 11, 2024
Maintains: Buy
Price Target: $115 → $125
Current: $148.22
Upside: -15.67%
Charles River Laboratories International
Jun 28, 2024
Downgrades: Hold
Price Target: n/a
Current: $138.79
Upside: -
Amgen
Jun 27, 2024
Maintains: Buy
Price Target: $300 → $340
Current: $265.86
Upside: +27.89%
McKesson
Jun 24, 2024
Maintains: Buy
Price Target: $570 → $670
Current: $693.46
Upside: -3.38%
Zimmer Biomet Holdings
May 21, 2024
Upgrades: Buy
Price Target: $150
Current: $95.21
Upside: +57.55%
May 14, 2024
Maintains: Buy
Price Target: $770 → $840
Current: $734.57
Upside: +14.35%
May 9, 2024
Maintains: Buy
Price Target: $89 → $95
Current: $56.75
Upside: +67.40%
Apr 1, 2024
Maintains: Buy
Price Target: $80 → $110
Current: $69.87
Upside: +57.44%
Mar 25, 2024
Upgrades: Buy
Price Target: n/a
Current: $245.73
Upside: -
Mar 22, 2024
Downgrades: Hold
Price Target: n/a
Current: $22.28
Upside: -
Mar 13, 2024
Downgrades: Hold
Price Target: n/a
Current: $249.53
Upside: -
May 25, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $380.92
Upside: -18.62%
May 10, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $353.70
Upside: -12.36%
Dec 22, 2022
Maintains: Buy
Price Target: $265 → $320
Current: $536.51
Upside: -40.36%
Jul 28, 2022
Maintains: Buy
Price Target: $150 → $135
Current: $133.24
Upside: +1.32%
Jan 28, 2022
Upgrades: Buy
Price Target: $75
Current: $96.91
Upside: -22.61%
Nov 1, 2021
Downgrades: Hold
Price Target: n/a
Current: $46.45
Upside: -
Nov 1, 2021
Upgrades: Buy
Price Target: $110
Current: $75.97
Upside: +44.79%
Aug 27, 2021
Maintains: Buy
Price Target: $150 → $165
Current: $83.48
Upside: +97.65%
Aug 2, 2021
Downgrades: Hold
Price Target: n/a
Current: $7.11
Upside: -
Jun 18, 2021
Maintains: Buy
Price Target: $110 → $123
Current: $49.94
Upside: +145.29%
Apr 12, 2021
Downgrades: Hold
Price Target: n/a
Current: $67.57
Upside: -
Mar 10, 2021
Downgrades: Hold
Price Target: n/a
Current: $108.70
Upside: -
Mar 27, 2020
Reiterates: Buy
Price Target: $165 → $155
Current: $154.22
Upside: +0.51%